Delivery Order SPE2DB22D3011-SPE2DB25FP8UJ
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,584.18 and is a firm fixed-price delivery order with a completion date of June 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not...
This federal contract award, with the ID SPE2DB22D1041|SPE2DB25FTYR3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566611056 - Ondansetron HCL 4 mg Tablet 30s, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,079.44 and is a Firm Fixed Price Delivery Order contract. It does not have any set-aside designation,...
This federal contract award, valued at $3,501.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 25, 2024. The contract was not set aside for any specific business type....
This federal contract award, valued at $12,458.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,678 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This federal contract award, valued at $33,815.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 2, 2024 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $2,919.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,545.55 Firm Fixed Price Delivery Order is for the supply of 500 units of Ondansetron HCL 4 mg Tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This award is associated with a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 MG tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $16,741.02 and a completion date of April 4, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This federal contract award, with the ID SPE2DB22D3011|SPE2DB25FP9DX, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,138,858 units of Ondansetron HCL 4 MG Tablets, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a ceiling value of $2,305.52. The award date is February 3, 2025, and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $8,894.00 and is a firm fixed-price delivery order, with an ultimate completion date of April 22, 2025. This contract is not designated as a set-aside and is open to full...